139 Live Notices for Brinzolamide Tenders
Showing 1 to 20
Supply of Medicine and Medical / Surgical equipments : Brinzolamide Eye Drops 1%, in 5ml Dropper\nBottle\nBrinzolamide eye drops 1%,in 5ml dropper bottle\nEach 5ml dropper bottle to contain 1% w/v\nBrinzolamide for ophthalmic use\nNote:\n1.The tamper - evident container (dropper bottle)\nshould assure the sterility of the product.\n3.Product should be stable for minimum of 24\nmonths when stored at a temperature range of\n28'C-32'C\n4.Each bottle should be labelled accordingly.\n5.Product should be individually packed in light\nresistant boxes/cartons with a leaflet .\nPacking : One vial etc .
20 Feb 2025
03 Apr 2025Open House Pharmaceutical Dact Treaties Brinzolamid And Brimonidin, Atc S01Ec24
Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Combination Of Brinzolamide And Timolol (Atc: S01Ed67).
Medicines Containing The Active Ingredient Combination Brinzolamide And Brimonidine (Atc: S01Ec24)
Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Combination Of Brinzolamide And Timolol (Atc: S01Ed67).
Conclusion Of Non-Exclusive Discount Agreements According To §130A Para.8 Sgb V For Various Active Ingredients/Combinations With The Possibility Of Conclusion At Any Time Within The Framework Of The So-Called Open House Procedure
Conclusion Of Non-Exclusive Discount Agreements According To §130A Para.8 Sgb V For Various Active Ingredients/Combinations With The Possibility Of Conclusion At Any Time Within The Framework Of The So-Called Open House Procedure
Open House Discount Agreements 2024-13
Medicines Containing The Active Ingredient Combination Brinzolamide And Timolol (Atc: S01Ed67)
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Brinzolamide/Timolol (Official Atc Code: S01Ed67)
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Brinzolamide/Timolol (Official Atc Code: S01Ed67)
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Brinzolamide/Timolol (Official Atc Code: S01Ed67)
Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Combination Of Brinzolamide And Brimonidine (Atc Code: S01Ec24).
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredients Brinzolamide And Brimonidine (S01Ec24) Within The Framework Of A So-Called Open-House Model.
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredients Brinzolamide And Brimonidine (S01Ec24) Within The Framework Of A So-Called Open-House Model.
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Timolol + Brinzolamide, Atc S01Ed67 (Obg) For The Period 01.11.2024 - 31.10.2026
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Timolol + Brinzolamide, Atc S01Ed67 (Obg) For The Period 01.11.2024 - 31.10.2026
Pharmaceutical Discount Agreements From 1 November 2024 For Various Active Ingredients As Part Of An Open House Procedure
Pharmaceutical Discount Agreements From 1 November 2024 For Various Active Ingredients As Part Of An Open House Procedure
Pharmaceutical Discount Agreements From 1 November 2024 For Various Active Ingredients As Part Of An Open House Procedure
Tenders by Country